ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Gastroenterology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,553Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 395

$979K Total Retail Price of All Prescriptions

Rank: 3 out of 395

546 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 546 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

13% of this provider’s 546 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 9,452 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 40%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $146 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 5.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 496 248 1 1
FUROSEMIDE 476 353 2 12
METOPROLOL TARTRATE 332 247 3 17
SIMVASTATIN 317 236 4 5
LEVOTHYROXINE SODIUM 299 269 5 13
WARFARIN SODIUM 264 191 6 32
AMLODIPINE BESYLATE 262 198 7 6
RANITIDINE HCL 260 99 8 11
RISPERIDONE 256 210 9 50
FENTANYL 219 161 S2 10 72
ZOLPIDEM TARTRATE 201 131 11 29
TAMSULOSIN HCL 199 122 12 44
HYDROCODONE-ACETAMINOPHEN 192 121 S3 13 46
OXYCODONE HCL 186 46 S2 14 86
DONEPEZIL HCL 184 160 15 34
NEXIUM 173 95 16 2
FAMOTIDINE 164 130 17 9
SERTRALINE HCL 163 110 18 54
METOPROLOL SUCCINATE 163 98 18 21
LANTUS 158 103 20 73
NAMENDA 154 142 21 59
LISINOPRIL 153 99 22 25
OXYCODONE-ACETAMINOPHEN 152 116 S2 23 53
PANTOPRAZOLE SODIUM 150 98 24 3
CARVEDILOL 135 106 25 52
METFORMIN HCL 135 107 25 16
LACTULOSE 134 98 27 20
DIVALPROEX SODIUM 132 54 28 80
CITALOPRAM HBR 131 101 29 66
NOVOLOG FLEXPEN 126 81 30 120
QUETIAPINE FUMARATE 126 104 30 120
CLOPIDOGREL 125 91 32 41
GABAPENTIN 120 43 33 49
ESCITALOPRAM OXALATE 118 80 34 89
DIGOXIN 117 104 35 97
DICYCLOMINE HCL 116 44 36 10
CIPROFLOXACIN HCL 109 60 37 91
KLOR-CON M20 107 78 38 130
ATORVASTATIN CALCIUM 104 73 39 14
XIFAXAN 99 47 40 73
LANTUS SOLOSTAR 98 76 41 96
SINGULAIR 98 39 41 92
MUPIROCIN 96 51 43 103
ISOSORBIDE MONONITRATE ER 95 80 44 88
CEPHALEXIN 95 65 44 136
IPRATROPIUM-ALBUTEROL 92 32 46 140
POTASSIUM CHLORIDE 85 69 47 42
CREON 83 41 48 38
NOVOFINE AUTOCOVER 81 46 49 146
JANUVIA 80 76 50 90
ALLOPURINOL 78 56 51 119
CRESTOR 77 28 52 37
SPIRONOLACTONE 76 31 53 68
LAMOTRIGINE 76 13 53 148
LEVETIRACETAM 75 33 55 110
HYDROCHLOROTHIAZIDE 74 65 56 22
IBUPROFEN 74 43 56 100
PLAVIX 73 50 58 70
FINASTERIDE 63 61 59 108
NOVOLOG 61 48 60 165
TRAMADOL HCL 60 27 61 39
DIOVAN 60 47 61 33
PAROXETINE HCL 58 41 63 75
PREDNISONE 58 41 63 95
CLONIDINE HCL 58 37 63 116
PROAIR HFA 58 14 63 98
MORPHINE SULFATE 58 17 S2 63 169
ADVAIR DISKUS 57 53 68 83
TRAZODONE HCL 57 12 68 171
CYCLOBENZAPRINE HCL 57 0 R 68 123
SEROQUEL 56 42 71 173
METOCLOPRAMIDE HCL 56 21 71 23
RAMIPRIL 55 39 73 48
OXYCODONE HCL-ACETAMINOPHEN 55 0 S2 73 175
MIRTAZAPINE 53 41 75 93
GLIMEPIRIDE 53 23 75 79
AZITHROMYCIN 52 30 77 61
PROCHLORPERAZINE MALEATE 51 0 78 109
SPIRIVA 51 38 78 183
PRAMIPEXOLE DIHYDROCHLORIDE 50 41 80 188
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.